+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Closed System Drug Transfer Device: Global Opportunity Analysis and Industry Forecast, 2024-2033

  • PDF Icon

    Report

  • 216 Pages
  • July 2024
  • Region: Global
  • Allied Market Research
  • ID: 5994263
Description Jump to:
The closed system drug transfer device (CSTD) market was valued at $0.8 billion in 2023 and is projected to reach $3.6 billion by 2033, growing at a CAGR of 15.7% from 2024 to 2033.

A closed system drug transfer device (CSTD) is a medical equipment which prevents contact between the inner environment of a system and the outer surroundings. CSTD forbids the entry of contaminants from the surroundings into medical equipment or system and prohibits the evasion of hazardous chemicals or vapors from the system to the external environment. These devices are critical for the safety of both patients and the medical professionals working in a hospital setting from probable cytotoxic or teratogenic agents.

With increasing prevalence of cancer and other chronic diseases, the adoption of CSTD is becoming essential in most healthcare settings, hence driving the growth of the market. In addition, implementation of regulatory mandates by several governing bodies such as Occupational Safety and Health Administration and the United States Pharmacopeia is boosting the demand for CSTDs. The integration of CSTDs with automation & robotics is a trend gaining significant prominence in pharmacies and drug preparation facilities to ensure efficient handling and usage of hazardous chemicals.

However, technical hurdles associated with the compatibility of CSTDs with diverse sizes of syringes, drug vials, and infusion systems pose the risk of malfunctions and hamper the development of the closed system drug transfer device (CSTD) market. Moreover, the usage of CSTDs requires high proficiency and specialized training, which is usually resource-intensive and laborious. This hampers the market growth. Contrarily, the exponentially rising cases of cancer are anticipated to present lucrative growth opportunities for the market. The number of cancer cases are expected to increase at the rate of 30 million new cases per year by 2040, thereby necessitating the use of CSTDs in hospitals.

Segment Review

The closed system drug transfer device (CSTD) market is segmented into type, component, end user, and region. On the basis of type, the market is bifurcated into membrane to membrane and needleless. Depending on component, it is divided into barrier type CSTDs and air cleaning CSTDs. As per end user, it is categorized into hospitals & clinics, oncology centers, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Findings

On the basis of type, the membrane to membrane segment dominates the closed system drug transfer device (CSTD) market.

As per end user, the hospitals & clinics segment holds a high share of the market.

Region wise, North America is the major revenue generator of the closed system drug transfer device (CSTD) market.

Competition Analysis

The key players operating in the global closed system drug transfer device (CSTD) market include B. Braun Holding GmbH & Co. KG, Baxter International, Becton, Dickinson and Company, Caragen Ltd., Corvida Medical, Equashield, FIMI Opportunity Funds (Simplivia Healthcare), ICU Medical, JCB Co Ltd., and Yukon Medical. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships, to strengthen their foothold in the competitive market.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Regulatory Guidelines
  • Additional company profiles with specific to client's interest
  • Average Selling Price Analysis / Price Point Analysis
  • Historic market data
  • Reimbursement Scenario

Key Market Segments

By Component

  • Barrier type CSTDs
  • Air cleaning CSTDs

By End User

  • Hospitals and Clinics
  • Oncology Centers
  • Others

By Region

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • France
  • Germany
  • Italy
  • Spain
  • UK
  • Rest of Europe
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia-Pacific
  • LAMEA
  • Brazil
  • South Africa
  • Saudi Arabia
  • Rest of LAMEA

By Type

  • Membrane to membrane
  • Needleless
Key Market Players
  • B. Braun Holding GmbH & Co. KG
  • Baxter International
  • Becton, Dickinson and Company
  • Caragen Ltd.
  • Corvida Medical
  • Equashield
  • FIMI Opportunity Funds (Simplivia Healthcare)
  • ICU Medical
  • JCB Co Ltd.
  • Yukon Medical

 

Please note:

  • Online Access price format is valid for 60 days access. Printing is not enabled.
  • PDF Single and Enterprise price formats enable printing.

 

Table of Contents

CHAPTER 1: INTRODUCTION
1.1. Report Description
1.2. Key Market Segments
1.3. Key Benefits
1.4. Research Methodology
1.4.1. Primary Research
1.4.2. Secondary Research
1.4.3. Analyst Tools and Models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET LANDSCAPE
3.1. Market Definition and Scope
3.2. Key Findings
3.2.1. Top Investment Pockets
3.2.2. Top Winning Strategies
3.3. Porter's Five Forces Analysis
3.3.1. Bargaining Power of Suppliers
3.3.2. Threat of New Entrants
3.3.3. Threat of Substitutes
3.3.4. Competitive Rivalry
3.3.5. Bargaining Power among Buyers
3.4. Market Dynamics
3.4.1. Drivers
3.4.2. Restraints
3.4.3. Opportunities
CHAPTER 4: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY TYPE
4.1. Market Overview
4.1.1 Market Size and Forecast, By Type
4.2. Membrane To Membrane
4.2.1. Key Market Trends, Growth Factors and Opportunities
4.2.2. Market Size and Forecast, By Region
4.2.3. Market Share Analysis, By Country
4.3. Needleless
4.3.1. Key Market Trends, Growth Factors and Opportunities
4.3.2. Market Size and Forecast, By Region
4.3.3. Market Share Analysis, By Country
CHAPTER 5: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY COMPONENT
5.1. Market Overview
5.1.1 Market Size and Forecast, By Component
5.2. Barrier Type CSTDs
5.2.1. Key Market Trends, Growth Factors and Opportunities
5.2.2. Market Size and Forecast, By Region
5.2.3. Market Share Analysis, By Country
5.3. Air Cleaning CSTDs
5.3.1. Key Market Trends, Growth Factors and Opportunities
5.3.2. Market Size and Forecast, By Region
5.3.3. Market Share Analysis, By Country
CHAPTER 6: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY END USER
6.1. Market Overview
6.1.1 Market Size and Forecast, By End User
6.2. Hospitals And Clinics
6.2.1. Key Market Trends, Growth Factors and Opportunities
6.2.2. Market Size and Forecast, By Region
6.2.3. Market Share Analysis, By Country
6.3. Oncology Centers
6.3.1. Key Market Trends, Growth Factors and Opportunities
6.3.2. Market Size and Forecast, By Region
6.3.3. Market Share Analysis, By Country
6.4. Others
6.4.1. Key Market Trends, Growth Factors and Opportunities
6.4.2. Market Size and Forecast, By Region
6.4.3. Market Share Analysis, By Country
CHAPTER 7: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY REGION
7.1. Market Overview
7.1.1 Market Size and Forecast, By Region
7.2. North America
7.2.1. Key Market Trends and Opportunities
7.2.2. Market Size and Forecast, By Type
7.2.3. Market Size and Forecast, By Component
7.2.4. Market Size and Forecast, By End User
7.2.5. Market Size and Forecast, By Country
7.2.6. U.S. Closed System Drug Transfer Device (CSTD) Market
7.2.6.1. Market Size and Forecast, By Type
7.2.6.2. Market Size and Forecast, By Component
7.2.6.3. Market Size and Forecast, By End User
7.2.7. Canada Closed System Drug Transfer Device (CSTD) Market
7.2.7.1. Market Size and Forecast, By Type
7.2.7.2. Market Size and Forecast, By Component
7.2.7.3. Market Size and Forecast, By End User
7.2.8. Mexico Closed System Drug Transfer Device (CSTD) Market
7.2.8.1. Market Size and Forecast, By Type
7.2.8.2. Market Size and Forecast, By Component
7.2.8.3. Market Size and Forecast, By End User
7.3. Europe
7.3.1. Key Market Trends and Opportunities
7.3.2. Market Size and Forecast, By Type
7.3.3. Market Size and Forecast, By Component
7.3.4. Market Size and Forecast, By End User
7.3.5. Market Size and Forecast, By Country
7.3.6. France Closed System Drug Transfer Device (CSTD) Market
7.3.6.1. Market Size and Forecast, By Type
7.3.6.2. Market Size and Forecast, By Component
7.3.6.3. Market Size and Forecast, By End User
7.3.7. Germany Closed System Drug Transfer Device (CSTD) Market
7.3.7.1. Market Size and Forecast, By Type
7.3.7.2. Market Size and Forecast, By Component
7.3.7.3. Market Size and Forecast, By End User
7.3.8. Italy Closed System Drug Transfer Device (CSTD) Market
7.3.8.1. Market Size and Forecast, By Type
7.3.8.2. Market Size and Forecast, By Component
7.3.8.3. Market Size and Forecast, By End User
7.3.9. Spain Closed System Drug Transfer Device (CSTD) Market
7.3.9.1. Market Size and Forecast, By Type
7.3.9.2. Market Size and Forecast, By Component
7.3.9.3. Market Size and Forecast, By End User
7.3.10. UK Closed System Drug Transfer Device (CSTD) Market
7.3.10.1. Market Size and Forecast, By Type
7.3.10.2. Market Size and Forecast, By Component
7.3.10.3. Market Size and Forecast, By End User
7.3.11. Rest of Europe Closed System Drug Transfer Device (CSTD) Market
7.3.11.1. Market Size and Forecast, By Type
7.3.11.2. Market Size and Forecast, By Component
7.3.11.3. Market Size and Forecast, By End User
7.4. Asia-Pacific
7.4.1. Key Market Trends and Opportunities
7.4.2. Market Size and Forecast, By Type
7.4.3. Market Size and Forecast, By Component
7.4.4. Market Size and Forecast, By End User
7.4.5. Market Size and Forecast, By Country
7.4.6. China Closed System Drug Transfer Device (CSTD) Market
7.4.6.1. Market Size and Forecast, By Type
7.4.6.2. Market Size and Forecast, By Component
7.4.6.3. Market Size and Forecast, By End User
7.4.7. Japan Closed System Drug Transfer Device (CSTD) Market
7.4.7.1. Market Size and Forecast, By Type
7.4.7.2. Market Size and Forecast, By Component
7.4.7.3. Market Size and Forecast, By End User
7.4.8. India Closed System Drug Transfer Device (CSTD) Market
7.4.8.1. Market Size and Forecast, By Type
7.4.8.2. Market Size and Forecast, By Component
7.4.8.3. Market Size and Forecast, By End User
7.4.9. South Korea Closed System Drug Transfer Device (CSTD) Market
7.4.9.1. Market Size and Forecast, By Type
7.4.9.2. Market Size and Forecast, By Component
7.4.9.3. Market Size and Forecast, By End User
7.4.10. Australia Closed System Drug Transfer Device (CSTD) Market
7.4.10.1. Market Size and Forecast, By Type
7.4.10.2. Market Size and Forecast, By Component
7.4.10.3. Market Size and Forecast, By End User
7.4.11. Rest of Asia-Pacific Closed System Drug Transfer Device (CSTD) Market
7.4.11.1. Market Size and Forecast, By Type
7.4.11.2. Market Size and Forecast, By Component
7.4.11.3. Market Size and Forecast, By End User
7.5. LAMEA
7.5.1. Key Market Trends and Opportunities
7.5.2. Market Size and Forecast, By Type
7.5.3. Market Size and Forecast, By Component
7.5.4. Market Size and Forecast, By End User
7.5.5. Market Size and Forecast, By Country
7.5.6. Brazil Closed System Drug Transfer Device (CSTD) Market
7.5.6.1. Market Size and Forecast, By Type
7.5.6.2. Market Size and Forecast, By Component
7.5.6.3. Market Size and Forecast, By End User
7.5.7. South Africa Closed System Drug Transfer Device (CSTD) Market
7.5.7.1. Market Size and Forecast, By Type
7.5.7.2. Market Size and Forecast, By Component
7.5.7.3. Market Size and Forecast, By End User
7.5.8. Saudi Arabia Closed System Drug Transfer Device (CSTD) Market
7.5.8.1. Market Size and Forecast, By Type
7.5.8.2. Market Size and Forecast, By Component
7.5.8.3. Market Size and Forecast, By End User
7.5.9. Rest of LAMEA Closed System Drug Transfer Device (CSTD) Market
7.5.9.1. Market Size and Forecast, By Type
7.5.9.2. Market Size and Forecast, By Component
7.5.9.3. Market Size and Forecast, By End User
CHAPTER 8: COMPETITIVE LANDSCAPE
8.1. Introduction
8.2. Top Winning Strategies
8.3. Product Mapping of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Top Player Positioning, 2023
CHAPTER 9: COMPANY PROFILES
9.1. B. Braun Holding GmbH And Co. KG
9.1.1. Company Overview
9.1.2. Key Executives
9.1.3. Company Snapshot
9.1.4. Operating Business Segments
9.1.5. Product Portfolio
9.1.6. Business Performance
9.1.7. Key Strategic Moves and Developments
9.2. Baxter International
9.2.1. Company Overview
9.2.2. Key Executives
9.2.3. Company Snapshot
9.2.4. Operating Business Segments
9.2.5. Product Portfolio
9.2.6. Business Performance
9.2.7. Key Strategic Moves and Developments
9.3. Becton, Dickinson And Company
9.3.1. Company Overview
9.3.2. Key Executives
9.3.3. Company Snapshot
9.3.4. Operating Business Segments
9.3.5. Product Portfolio
9.3.6. Business Performance
9.3.7. Key Strategic Moves and Developments
9.4. Caragen Ltd.
9.4.1. Company Overview
9.4.2. Key Executives
9.4.3. Company Snapshot
9.4.4. Operating Business Segments
9.4.5. Product Portfolio
9.4.6. Business Performance
9.4.7. Key Strategic Moves and Developments
9.5. Corvida Medical
9.5.1. Company Overview
9.5.2. Key Executives
9.5.3. Company Snapshot
9.5.4. Operating Business Segments
9.5.5. Product Portfolio
9.5.6. Business Performance
9.5.7. Key Strategic Moves and Developments
9.6. Equashield
9.6.1. Company Overview
9.6.2. Key Executives
9.6.3. Company Snapshot
9.6.4. Operating Business Segments
9.6.5. Product Portfolio
9.6.6. Business Performance
9.6.7. Key Strategic Moves and Developments
9.7. FIMI Opportunity Funds (Simplivia Healthcare)
9.7.1. Company Overview
9.7.2. Key Executives
9.7.3. Company Snapshot
9.7.4. Operating Business Segments
9.7.5. Product Portfolio
9.7.6. Business Performance
9.7.7. Key Strategic Moves and Developments
9.8. ICU Medical
9.8.1. Company Overview
9.8.2. Key Executives
9.8.3. Company Snapshot
9.8.4. Operating Business Segments
9.8.5. Product Portfolio
9.8.6. Business Performance
9.8.7. Key Strategic Moves and Developments
9.9. JCB Co Ltd.
9.9.1. Company Overview
9.9.2. Key Executives
9.9.3. Company Snapshot
9.9.4. Operating Business Segments
9.9.5. Product Portfolio
9.9.6. Business Performance
9.9.7. Key Strategic Moves and Developments
9.10. Yukon Medical
9.10.1. Company Overview
9.10.2. Key Executives
9.10.3. Company Snapshot
9.10.4. Operating Business Segments
9.10.5. Product Portfolio
9.10.6. Business Performance
9.10.7. Key Strategic Moves and Developments
LIST OF TABLES
Table 1. Global Closed System Drug Transfer Device (Cstd) Market, by Type, 2024 - 2033 ($Billion)
Table 2. Closed System Drug Transfer Device (Cstd) Market for Membrane to Membrane, by Region, 2024 - 2033 ($Billion)
Table 3. Closed System Drug Transfer Device (Cstd) Market for Needleless, by Region, 2024 - 2033 ($Billion)
Table 4. Global Closed System Drug Transfer Device (Cstd) Market, by Component, 2024 - 2033 ($Billion)
Table 5. Closed System Drug Transfer Device (Cstd) Market for Barrier Type Cstds, by Region, 2024 - 2033 ($Billion)
Table 6. Closed System Drug Transfer Device (Cstd) Market for Air Cleaning Cstds, by Region, 2024 - 2033 ($Billion)
Table 7. Global Closed System Drug Transfer Device (Cstd) Market, by End-user, 2024 - 2033 ($Billion)
Table 8. Closed System Drug Transfer Device (Cstd) Market for Hospitals and Clinics, by Region, 2024 - 2033 ($Billion)
Table 9. Closed System Drug Transfer Device (Cstd) Market for Oncology Centers, by Region, 2024 - 2033 ($Billion)
Table 10. Closed System Drug Transfer Device (Cstd) Market for Others, by Region, 2024 - 2033 ($Billion)
Table 11. Closed System Drug Transfer Device (Cstd) Market, by Region, 2024 - 2033 ($Billion)
Table 12. North America Closed System Drug Transfer Device (Cstd) Market, by Country, 2024 - 2033 ($Billion)
Table 13. North America Closed System Drug Transfer Device (Cstd) Market, by Type, 2024 - 2033 ($Billion)
Table 14. North America Closed System Drug Transfer Device (Cstd) Market, by Component, 2024 - 2033 ($Billion)
Table 15. North America Closed System Drug Transfer Device (Cstd) Market, by End-user, 2024 - 2033 ($Billion)
Table 16. U.S. Closed System Drug Transfer Device (Cstd) Market, by Type, 2024 - 2033 ($Billion)
Table 17. U.S. Closed System Drug Transfer Device (Cstd) Market, by Component, 2024 - 2033 ($Billion)
Table 18. U.S. Closed System Drug Transfer Device (Cstd) Market, by End-user, 2024 - 2033 ($Billion)
Table 19. Canada Closed System Drug Transfer Device (Cstd) Market, by Type, 2024 - 2033 ($Billion)
Table 20. Canada Closed System Drug Transfer Device (Cstd) Market, by Component, 2024 - 2033 ($Billion)
Table 21. Canada Closed System Drug Transfer Device (Cstd) Market, by End-user, 2024 - 2033 ($Billion)
Table 22. Mexico Closed System Drug Transfer Device (Cstd) Market, by Type, 2024 - 2033 ($Billion)
Table 23. Mexico Closed System Drug Transfer Device (Cstd) Market, by Component, 2024 - 2033 ($Billion)
Table 24. Mexico Closed System Drug Transfer Device (Cstd) Market, by End-user, 2024 - 2033 ($Billion)
Table 25. Europe Closed System Drug Transfer Device (Cstd) Market, by Country, 2024 - 2033 ($Billion)
Table 26. Europe Closed System Drug Transfer Device (Cstd) Market, by Type, 2024 - 2033 ($Billion)
Table 27. Europe Closed System Drug Transfer Device (Cstd) Market, by Component, 2024 - 2033 ($Billion)
Table 28. Europe Closed System Drug Transfer Device (Cstd) Market, by End-user, 2024 - 2033 ($Billion)
Table 29. France Closed System Drug Transfer Device (Cstd) Market, by Type, 2024 - 2033 ($Billion)
Table 30. France Closed System Drug Transfer Device (Cstd) Market, by Component, 2024 - 2033 ($Billion)
Table 31. France Closed System Drug Transfer Device (Cstd) Market, by End-user, 2024 - 2033 ($Billion)
Table 32. Germany Closed System Drug Transfer Device (Cstd) Market, by Type, 2024 - 2033 ($Billion)
Table 33. Germany Closed System Drug Transfer Device (Cstd) Market, by Component, 2024 - 2033 ($Billion)
Table 34. Germany Closed System Drug Transfer Device (Cstd) Market, by End-user, 2024 - 2033 ($Billion)
Table 35. Italy Closed System Drug Transfer Device (Cstd) Market, by Type, 2024 - 2033 ($Billion)
Table 36. Italy Closed System Drug Transfer Device (Cstd) Market, by Component, 2024 - 2033 ($Billion)
Table 37. Italy Closed System Drug Transfer Device (Cstd) Market, by End-user, 2024 - 2033 ($Billion)
Table 38. Spain Closed System Drug Transfer Device (Cstd) Market, by Type, 2024 - 2033 ($Billion)
Table 39. Spain Closed System Drug Transfer Device (Cstd) Market, by Component, 2024 - 2033 ($Billion)
Table 40. Spain Closed System Drug Transfer Device (Cstd) Market, by End-user, 2024 - 2033 ($Billion)
Table 41. UK Closed System Drug Transfer Device (Cstd) Market, by Type, 2024 - 2033 ($Billion)
Table 42. UK Closed System Drug Transfer Device (Cstd) Market, by Component, 2024 - 2033 ($Billion)
Table 43. UK Closed System Drug Transfer Device (Cstd) Market, by End-user, 2024 - 2033 ($Billion)
Table 44. Rest of Europe Closed System Drug Transfer Device (Cstd) Market, by Type, 2024 - 2033 ($Billion)
Table 45. Rest of Europe Closed System Drug Transfer Device (Cstd) Market, by Component, 2024 - 2033 ($Billion)
Table 46. Rest of Europe Closed System Drug Transfer Device (Cstd) Market, by End-user, 2024 - 2033 ($Billion)
Table 47. Asia-Pacific Closed System Drug Transfer Device (Cstd) Market, by Country, 2024 - 2033 ($Billion)
Table 48. Asia-Pacific Closed System Drug Transfer Device (Cstd) Market, by Type, 2024 - 2033 ($Billion)
Table 49. Asia-Pacific Closed System Drug Transfer Device (Cstd) Market, by Component, 2024 - 2033 ($Billion)
Table 50. Asia-Pacific Closed System Drug Transfer Device (Cstd) Market, by End-user, 2024 - 2033 ($Billion)
Table 51. China Closed System Drug Transfer Device (Cstd) Market, by Type, 2024 - 2033 ($Billion)
Table 52. China Closed System Drug Transfer Device (Cstd) Market, by Component, 2024 - 2033 ($Billion)
Table 53. China Closed System Drug Transfer Device (Cstd) Market, by End-user, 2024 - 2033 ($Billion)
Table 54. Japan Closed System Drug Transfer Device (Cstd) Market, by Type, 2024 - 2033 ($Billion)
Table 55. Japan Closed System Drug Transfer Device (Cstd) Market, by Component, 2024 - 2033 ($Billion)
Table 56. Japan Closed System Drug Transfer Device (Cstd) Market, by End-user, 2024 - 2033 ($Billion)
Table 57. India Closed System Drug Transfer Device (Cstd) Market, by Type, 2024 - 2033 ($Billion)
Table 58. India Closed System Drug Transfer Device (Cstd) Market, by Component, 2024 - 2033 ($Billion)
Table 59. India Closed System Drug Transfer Device (Cstd) Market, by End-user, 2024 - 2033 ($Billion)
Table 60. South Korea Closed System Drug Transfer Device (Cstd) Market, by Type, 2024 - 2033 ($Billion)
Table 61. South Korea Closed System Drug Transfer Device (Cstd) Market, by Component, 2024 - 2033 ($Billion)
Table 62. South Korea Closed System Drug Transfer Device (Cstd) Market, by End-user, 2024 - 2033 ($Billion)
Table 63. Australia Closed System Drug Transfer Device (Cstd) Market, by Type, 2024 - 2033 ($Billion)
Table 64. Australia Closed System Drug Transfer Device (Cstd) Market, by Component, 2024 - 2033 ($Billion)
Table 65. Australia Closed System Drug Transfer Device (Cstd) Market, by End-user, 2024 - 2033 ($Billion)
Table 66. Rest of Asia-Pacific Closed System Drug Transfer Device (Cstd) Market, by Type, 2024 - 2033 ($Billion)
Table 67. Rest of Asia-Pacific Closed System Drug Transfer Device (Cstd) Market, by Component, 2024 - 2033 ($Billion)
Table 68. Rest of Asia-Pacific Closed System Drug Transfer Device (Cstd) Market, by End-user, 2024 - 2033 ($Billion)
Table 69. LAMEA Closed System Drug Transfer Device (Cstd) Market, by Country, 2024 - 2033 ($Billion)
Table 70. LAMEA Closed System Drug Transfer Device (Cstd) Market, by Type, 2024 - 2033 ($Billion)
Table 71. LAMEA Closed System Drug Transfer Device (Cstd) Market, by Component, 2024 - 2033 ($Billion)
Table 72. LAMEA Closed System Drug Transfer Device (Cstd) Market, by End-user, 2024 - 2033 ($Billion)
Table 73. Brazil Closed System Drug Transfer Device (Cstd) Market, by Type, 2024 - 2033 ($Billion)
Table 74. Brazil Closed System Drug Transfer Device (Cstd) Market, by Component, 2024 - 2033 ($Billion)
Table 75. Brazil Closed System Drug Transfer Device (Cstd) Market, by End-user, 2024 - 2033 ($Billion)
Table 76. South Africa Closed System Drug Transfer Device (Cstd) Market, by Type, 2024 - 2033 ($Billion)
Table 77. South Africa Closed System Drug Transfer Device (Cstd) Market, by Component, 2024 - 2033 ($Billion)
Table 78. South Africa Closed System Drug Transfer Device (Cstd) Market, by End-user, 2024 - 2033 ($Billion)
Table 79. Saudi Arabia Closed System Drug Transfer Device (Cstd) Market, by Type, 2024 - 2033 ($Billion)
Table 80. Saudi Arabia Closed System Drug Transfer Device (Cstd) Market, by Component, 2024 - 2033 ($Billion)
Table 81. Saudi Arabia Closed System Drug Transfer Device (Cstd) Market, by End-user, 2024 - 2033 ($Billion)
Table 82. Rest of LAMEA Closed System Drug Transfer Device (Cstd) Market, by Type, 2024 - 2033 ($Billion)
Table 83. Rest of LAMEA Closed System Drug Transfer Device (Cstd) Market, by Component, 2024 - 2033 ($Billion)
Table 84. Rest of LAMEA Closed System Drug Transfer Device (Cstd) Market, by End-user, 2024 - 2033 ($Billion)
Table 85. B. Braun Holding GmbH and Co. KG: Key Executives
Table 86. B. Braun Holding GmbH and Co. KG: Company Snapshot
Table 87. B. Braun Holding GmbH and Co. KG: Operating Segments
Table 88. B. Braun Holding GmbH and Co. KG: Product Portfolio
Table 89. B. Braun Holding GmbH and Co. KG: Key Strategic Moves and Developments
Table 90. Baxter International: Key Executives
Table 91. Baxter International: Company Snapshot
Table 92. Baxter International: Operating Segments
Table 93. Baxter International: Product Portfolio
Table 94. Baxter International: Key Strategic Moves and Developments
Table 95. Becton, Dickinson and Company: Key Executives
Table 96. Becton, Dickinson and Company: Company Snapshot
Table 97. Becton, Dickinson and Company: Operating Segments
Table 98. Becton, Dickinson and Company: Product Portfolio
Table 99. Becton, Dickinson and Company: Key Strategic Moves and Developments
Table 100. Caragen Ltd.: Key Executives
Table 101. Caragen Ltd.: Company Snapshot
Table 102. Caragen Ltd.: Operating Segments
Table 103. Caragen Ltd.: Product Portfolio
Table 104. Caragen Ltd.: Key Strategic Moves and Developments
Table 105. Corvida Medical: Key Executives
Table 106. Corvida Medical: Company Snapshot
Table 107. Corvida Medical: Operating Segments
Table 108. Corvida Medical: Product Portfolio
Table 109. Corvida Medical: Key Strategic Moves and Developments
Table 110. Equashield: Key Executives
Table 111. Equashield: Company Snapshot
Table 112. Equashield: Operating Segments
Table 113. Equashield: Product Portfolio
Table 114. Equashield: Key Strategic Moves and Developments
Table 115. Fimi Opportunity Funds (Simplivia Healthcare) : Key Executives
Table 116. Fimi Opportunity Funds (Simplivia Healthcare) : Company Snapshot
Table 117. Fimi Opportunity Funds (Simplivia Healthcare) : Operating Segments
Table 118. Fimi Opportunity Funds (Simplivia Healthcare) : Product Portfolio
Table 119. Fimi Opportunity Funds (Simplivia Healthcare) : Key Strategic Moves and Developments
Table 120. Icu Medical: Key Executives
Table 121. Icu Medical: Company Snapshot
Table 122. Icu Medical: Operating Segments
Table 123. Icu Medical: Product Portfolio
Table 124. Icu Medical: Key Strategic Moves and Developments
Table 125. Jcb Co Ltd.: Key Executives
Table 126. Jcb Co Ltd.: Company Snapshot
Table 127. Jcb Co Ltd.: Operating Segments
Table 128. Jcb Co Ltd.: Product Portfolio
Table 129. Jcb Co Ltd.: Key Strategic Moves and Developments
Table 130. Yukon Medical: Key Executives
Table 131. Yukon Medical: Company Snapshot
Table 132. Yukon Medical: Operating Segments
Table 133. Yukon Medical: Product Portfolio
Table 134. Yukon Medical: Key Strategic Moves and Developments
LIST OF FIGURES
Figure 1. Global Closed System Drug Transfer Device (Cstd) Market, 2024 - 2033
Figure 2. Segmentation of Closed System Drug Transfer Device (Cstd) Market, 2024 - 2033
Figure 3. Top Investment Pocket in Closed System Drug Transfer Device (Cstd) Market
Figure 4. Moderate Bargaining Power of Buyers
Figure 5. Moderate Bargaining Power of Suppliers
Figure 6. Moderate Threat of New Entrants
Figure 7. Low Threat of Substitution
Figure 8. High Competitive Rivalry
Figure 9. Opportunities, Restraints and Drivers: Globalclosed System Drug Transfer Device (Cstd) Market
Figure 10. Global Closed System Drug Transfer Device (Cstd) Market Segmentation, by Type
Figure 11. Closed System Drug Transfer Device (Cstd) Market for Membrane to Membrane, by Country, 2024 - 2033 ($Billion)
Figure 12. Closed System Drug Transfer Device (Cstd) Market for Needleless, by Country, 2024 - 2033 ($Billion)
Figure 13. Global Closed System Drug Transfer Device (Cstd) Market Segmentation, by Component
Figure 14. Closed System Drug Transfer Device (Cstd) Market for Barrier Type Cstds, by Country, 2024 - 2033 ($Billion)
Figure 15. Closed System Drug Transfer Device (Cstd) Market for Air Cleaning Cstds, by Country, 2024 - 2033 ($Billion)
Figure 16. Global Closed System Drug Transfer Device (Cstd) Market Segmentation, by End-user
Figure 17. Closed System Drug Transfer Device (Cstd) Market for Hospitals and Clinics, by Country, 2024 - 2033 ($Billion)
Figure 18. Closed System Drug Transfer Device (Cstd) Market for Oncology Centers, by Country, 2024 - 2033 ($Billion)
Figure 19. Closed System Drug Transfer Device (Cstd) Market for Others, by Country, 2024 - 2033 ($Billion)
Figure 20. Top Winning Strategies, by Year, 2021-2023*
Figure 21. Top Winning Strategies, by Development, 2021-2023*
Figure 22. Top Winning Strategies, by Company, 2021-2023*
Figure 23. Product Mapping of Top 10 Players
Figure 24. Competitive Dashboard
Figure 25. Competitive Heatmap: Closed System Drug Transfer Device (Cstd) Market
Figure 26. Top Player Positioning, 2023
Figure 27. B. Braun Holding GmbH and Co. KG: Net Sales, 2021-2023 ($Billion)
Figure 28. B. Braun Holding GmbH and Co. KG: Revenue Share, by Segment, 2023 (%)
Figure 29. B. Braun Holding GmbH and Co. KG: Revenue Share, by Region, 2023 (%)
Figure 30. Baxter International: Net Sales, 2021-2023 ($Billion)
Figure 31. Baxter International: Revenue Share, by Segment, 2023 (%)
Figure 32. Baxter International: Revenue Share, by Region, 2023 (%)
Figure 33. Becton, Dickinson and Company: Net Sales, 2021-2023 ($Billion)
Figure 34. Becton, Dickinson and Company: Revenue Share, by Segment, 2023 (%)
Figure 35. Becton, Dickinson and Company: Revenue Share, by Region, 2023 (%)
Figure 36. Caragen Ltd.: Net Sales, 2021-2023 ($Billion)
Figure 37. Caragen Ltd.: Revenue Share, by Segment, 2023 (%)
Figure 38. Caragen Ltd.: Revenue Share, by Region, 2023 (%)
Figure 39. Corvida Medical: Net Sales, 2021-2023 ($Billion)
Figure 40. Corvida Medical: Revenue Share, by Segment, 2023 (%)
Figure 41. Corvida Medical: Revenue Share, by Region, 2023 (%)
Figure 42. Equashield: Net Sales, 2021-2023 ($Billion)
Figure 43. Equashield: Revenue Share, by Segment, 2023 (%)
Figure 44. Equashield: Revenue Share, by Region, 2023 (%)
Figure 45. Fimi Opportunity Funds (Simplivia Healthcare) : Net Sales, 2021-2023 ($Billion)
Figure 46. Fimi Opportunity Funds (Simplivia Healthcare) : Revenue Share, by Segment, 2023 (%)
Figure 47. Fimi Opportunity Funds (Simplivia Healthcare) : Revenue Share, by Region, 2023 (%)
Figure 48. Icu Medical: Net Sales, 2021-2023 ($Billion)
Figure 49. Icu Medical: Revenue Share, by Segment, 2023 (%)
Figure 50. Icu Medical: Revenue Share, by Region, 2023 (%)
Figure 51. Jcb Co Ltd.: Net Sales, 2021-2023 ($Billion)
Figure 52. Jcb Co Ltd.: Revenue Share, by Segment, 2023 (%)
Figure 53. Jcb Co Ltd.: Revenue Share, by Region, 2023 (%)
Figure 54. Yukon Medical: Net Sales, 2021-2023 ($Billion)
Figure 55. Yukon Medical: Revenue Share, by Segment, 2023 (%)
Figure 56. Yukon Medical: Revenue Share, by Region, 2023 (%)

Companies Mentioned

Key Market Players in the Closed System Drug Transfer Device include:
  • B. Braun Holding GmbH & Co. KG
  • Baxter International
  • Becton, Dickinson and Company
  • Caragen Ltd.
  • Corvida Medical
  • Equashield
  • FIMI Opportunity Funds (Simplivia Healthcare)
  • ICU Medical
  • JCB Co Ltd.
  • Yukon Medical

Methodology

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic news articles and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages216
PublishedJuly 2024
Forecast Period2023 - 2033
Estimated Market Value ( USD ) in 2023 $ 0.8 billion
Forecasted Market Value ( USD ) by 2033 $ 3.6 billion
Compound Annual Growth Rate15.7%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Intravenous (IV) Equipment Market Outlook, 2028 - Product Image

Intravenous (IV) Equipment Market Outlook, 2028

  • Report
  • 173 Pages
  • Global
From
South America Intravenous (IV) Equipment Market Outlook, 2028 - Product Image

South America Intravenous (IV) Equipment Market Outlook, 2028

  • Report
  • 78 Pages
From
Implantable Infusion Pumps Global Market Report 2024 - Product Image

Implantable Infusion Pumps Global Market Report 2024

  • Report
  • 175 Pages
  • Global
From
IV Fluid Transfer Drugs Device Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type - Product Image

IV Fluid Transfer Drugs Device Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • 102 Pages
  • Global
From
Injectable Drug Delivery Devices Global Market Report 2024 - Product Image

Injectable Drug Delivery Devices Global Market Report 2024

  • Report
  • 250 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.